VERSANT TELEVISION NETWORKS, LLC – Trademark Portfolio
Entity Type: 16
VERSANT TELEVISION NETWORKS, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 38 (Telecommunications) — 5 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include USA, SCIFI.COM, USA NETWORK, and HERE FOR THE CHARACTERS. The owner is based in NEW YORK, NY.
30 ROCKEFELLER PLAZA
NEW YORK, NY 10112
Showing of trademarks Trademarks
Trademark Classifications
VERSANT TELEVISION NETWORKS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does VERSANT TELEVISION NETWORKS, LLC have?
VERSANT TELEVISION NETWORKS, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does VERSANT TELEVISION NETWORKS, LLC file in?
VERSANT TELEVISION NETWORKS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 38 covers telecommunications.
What are VERSANT TELEVISION NETWORKS, LLC's most well-known trademarks?
VERSANT TELEVISION NETWORKS, LLC's registered trademark portfolio includes well-known marks such as USA, SCIFI.COM, USA NETWORK, and HERE FOR THE CHARACTERS. These are among 6 currently registered trademarks in the portfolio.
What is VERSANT TELEVISION NETWORKS, LLC's trademark registration success rate?
VERSANT TELEVISION NETWORKS, LLC has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.